SCHEMBL1224639

SCHEMBL1224639

COc1ccc(F)c(NCc2cccc(F)c2)n1.Oc1ccc(F)c(NCc2cccc(F)c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 5/20 0.43
RPS6KB1 P23443 5/20 0.43
CLK4 Q9HAZ1 2/20 0.42
APP P05067 2/20 0.42
AURKB Q96GD4 2/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
ABL1 P00519 1/20 0.41
LCK P06239 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
PDGFRB P09619 1/20 0.41
FGFR1 P11362 1/20 0.41
PRKACA P17612 1/20 0.41
FLT1 P17948 1/20 0.41
LTK P29376 1/20 0.41
GRK5 P34947 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192602 0.93 APP (0.47) AURKARPS6KB1CLK4APPAURKB
SCHEMBL1191456 0.89 APP (0.50) AURKARPS6KB1CLK4APPAURKB
SCHEMBL12468290 0.88 APP (0.44) AURKARPS6KB1CLK4APPAURKB
SCHEMBL1192074 0.76 APP (0.52) AURKARPS6KB1CLK4APPAURKB
SCHEMBL1192095 0.74 CCNE2 (0.47) AURKARPS6KB1CLK4APPAURKB
SCHEMBL28000657 0.70 KDM5A (0.52) AURKACLK4APPAURKBDAPK3
SCHEMBL22792188 0.69 BRAF (0.53) CLK4PDGFRBDYRK1AADORA2AADORA2B
SCHEMBL16041322 0.68 APP (0.50) AURKARPS6KB1CLK4APPAURKB
SCHEMBL27871448 0.67 CLK4 (0.51) AURKARPS6KB1CLK4APPAURKB
SCHEMBL1225589 0.65 APP (0.47) AURKARPS6KB1CLK4APPAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668162-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES Novartis AG (CH) 2013-12-04 EP disclosed
WO-2012101065-A2 PYRIMIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101066-A1 PYRIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
EP-2459535-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS Novartis AG (CH) 2012-06-06 EP disclosed
WO-2011012661-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS NOVARTIS AG (CH) 2011-02-03 WO disclosed